View all Online CME
View all HNC CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.



Continuing Education Information

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Supporter

This activity is funded entirely by Physicians’ Education Resource®, LLC.
8th Annual Multidisciplinary Symposium on Head and Neck Cancer® Medical Crossfire®



Release Date: April 10, 2014 Expiration Date: April 10, 2015
Media: Internet-based

Activity Overview

This installment of Medical Crossfire® provides an update on advances in the treatment of head and neck cancer. Modules focus on state-of-the-art management of locally advanced HPV-positive head and neck cancer, including approaches to de-intensification, transoral robotic surgery, and management of positive nodes after chemoradiation, as well as systemic therapy for metastatic HPV-negative head and neck cancer, including EGFR-targeted antibodies and small-molecule tyrosine kinase inhibitors. Expert faculty present the latest clinical data for standard and emerging treatment approaches, and discuss the application of available clinical evidence as well as their own patient management strategies in the clinic using actual case scenarios.

Instructions For This Activity & Receiving Credit

  • Once you begin the activity, please answer 4 demographic questions. This will allow you to proceed to the presentations.
  • Each presentation contains an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish each faculty presentation.
  • At the end of each faculty presentation, “educational content/video” link will be available with that faculty presentation videos/content for your reference.
  • If you close the web browser after you complete any of the faculty presentations, the “educational content/video” link will disappear and you will need to review the faculty presentation in its entirety to access the link to the “educational content/video” again.
  • In order to receive a CME certificate, participants must complete the activity.
  • Click on the "request CME credits" link at the end of the presentations. Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit.  Participants may immediately download a CME certificate upon completion of these steps.


 


Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with head and neck cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of head and neck cancer may also participate.


Learning Objectives

Upon completion of this activity, participants should be better prepared to:

  • Assess recent advances in the multimodal management of patients with locoregional head and neck cancer
  • Select patients with head and neck cancer who are most likely to benefit from an EGFR inhibitor
  • Formulate treatment plans for patients with head and neck cancer based on biomarker status and patient/tumor characteristics
  • Evaluate emerging agents currently in clinical trials for patients with head and neck cancer


Chair

Barbara A. Burtness, MD
Professor, Medical Oncology
Chief, Head and Neck Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA







Faculty

Robert L. Ferris, MD, PhD, FACS
Professor, Vice-Chair for Clinical Operations
Chief, Division of Head and Neck Surgery
Departments of Otolaryngology, Radiation Oncology, and Immunology
University of Pittsburgh Cancer Institute
Pittsburgh, PA






Thomas J. Galloway, MD
Attending Physician, Radiation Oncology
Fox Chase Cancer Center
Philadelphia, PA








Ranee Mehra, MD
Attending Physician, Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA








John A. "Drew" Ridge, MD, PhD, FACS
Chief, Head and Neck Surgery
Louis Della Penna Family Chair in Head and Neck Oncology
Fox Chase Cancer Center
Philadelphia, PA








Faculty and Staff Disclosures

The following individuals have no relevant financial relationships with commercial interests to disclose:
Robert L. Ferris, MD, PhD, FACS; Thomas J. Galloway, MD; John A. "Drew" Ridge, MD, PhD, FACS.

The staff of Physicians’ Education Resource®, LLC:
Wendy Ashmen; Dru S. Dace, PhD; Ann C. Lichti, CCMEP; and Susan Peck, PhD.

The following individuals have relevant financial relationships with commercial interests to disclose:
Barbara A. Burtness, MD – Grant/Research Support: Genentech, Curis, Inc., Boehringer Ingelheim, Pfizer Inc., Novartis Pharmaceuticals Corporation; Consultant: Cleveland BioLabs, Inc., Novartis Pharmaceuticals Corporation, VentiRx Pharmaceuticals, Bayer.
Ranee Mehra, MD – Consultant: Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation; Speaker’s Bureau: Pfizer Inc.; Spousal employment relationship: GlaxoSmithKline.

Off-Label Disclosure and Disclaimer

This CME activity will contain discussion of investigational, unapproved, or off-label use of drugs including but not limited to enzalutamide prior to chemotherapy and clinical trials with rhodium, abiraterone, and enzalutamide. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.


Disclaimer

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians' Education Resource®, LLC.


Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) ¦ Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise






Our Mission       |      Accreditation       |      Privacy Policy       |      Terms & Conditions of Use       |      Contact PER®
 
Copyright © 2014 Physicians' Education Resource®, LLC. All rights reserved.
Contact PER®
Physicians' Education Resource®, LLC
666 Plainsboro Rd. Suite 356
Plainsboro, NJ 08536

Phone (609) 378-3701
Fax (609) 257-0705
info@gotoper.com